annual ROE:
-25.08%-9.94%(-65.65%)Summary
- As of today (September 14, 2025), MLTX annual return on equity is -25.08%, with the most recent change of -9.94% (-65.65%) on December 31, 2024.
- During the last 3 years, MLTX annual ROE has risen by +81.31% (+76.43%).
- MLTX annual ROE is now -31250.00% below its all-time high of -0.08%, reached on December 1, 2020.
Performance
MLTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
-39.81%-9.57%(-31.65%)Summary
- As of today (September 14, 2025), MLTX quarterly return on equity is -39.81%, with the most recent change of -9.57% (-31.65%) on June 30, 2025.
- Over the past year, MLTX quarterly ROE has dropped by -28.54% (-253.24%).
- MLTX quarterly ROE is now -24781.25% below its all-time high of -0.16%, reached on December 1, 2020.
Performance
MLTX quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MLTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -65.7% | -253.2% |
| 3 y3 years | +76.4% | +51.3% |
| 5 y5 years | -10000.0% | -59.2% |
MLTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -65.7% | +88.9% | -267.3% | +68.1% |
| 5 y | 5-year | <-9999.0% | +88.9% | <-9999.0% | +68.1% |
| alltime | all time | <-9999.0% | +88.9% | <-9999.0% | +68.1% |
MLTX ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | -39.81%(+31.6%) |
| Mar 2025 | - | -30.24%(+27.0%) |
| Dec 2024 | -25.08%(+65.7%) | -23.82%(+48.6%) |
| Sep 2024 | - | -16.03%(+42.2%) |
| Jun 2024 | - | -11.27%(+4.0%) |
| Mar 2024 | - | -10.84%(-19.8%) |
| Dec 2023 | -15.14%(-93.3%) | -13.52%(-38.4%) |
| Sep 2023 | - | -21.96%(-36.7%) |
| Jun 2023 | - | -34.69%(-62.4%) |
| Mar 2023 | - | -92.36%(-25.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | -225.86%(+112.3%) | -124.70%(+20.0%) |
| Sep 2022 | - | -103.91%(+27.1%) |
| Jun 2022 | - | -81.74%(-17.9%) |
| Mar 2022 | - | -99.51%(+62.5%) |
| Dec 2021 | -106.39%(>+9900.0%) | -61.25%(+40.0%) |
| Sep 2021 | - | -43.74%(+12.2%) |
| Jun 2021 | - | -38.98%(>+9900.0%) |
| Mar 2021 | - | -0.22%(+37.5%) |
| Dec 2020 | -0.08% | -0.16%(-99.4%) |
| Sep 2020 | - | -25.00% |
FAQ
- What is MoonLake Immunotherapeutics annual return on equity?
- What is the all time high annual ROE for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual ROE year-on-year change?
- What is MoonLake Immunotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly ROE year-on-year change?
What is MoonLake Immunotherapeutics annual return on equity?
The current annual ROE of MLTX is -25.08%
What is the all time high annual ROE for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual return on equity is -0.08%
What is MoonLake Immunotherapeutics annual ROE year-on-year change?
Over the past year, MLTX annual return on equity has changed by -9.94% (-65.65%)
What is MoonLake Immunotherapeutics quarterly return on equity?
The current quarterly ROE of MLTX is -39.81%
What is the all time high quarterly ROE for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly return on equity is -0.16%
What is MoonLake Immunotherapeutics quarterly ROE year-on-year change?
Over the past year, MLTX quarterly return on equity has changed by -28.54% (-253.24%)